Table S2: On-Line Supplementary (Table S2): Medical Factors Associated with HAART Regimen Change at 12 Months After Initiation.

SWITCH
REGIMEN
N=610 (24.8%)
N(%) or
Median(IQR)
NO SWITCH
REGIMEN N=1847
(75.2%)
N(%) or
Median(IQR)
UNIVARIATE
ODDS RATIO
(95% CI)
P-
VALUE
Medical Illnesses
Cerebrovascular Disease 6 (1.0%) 9 (0.5%) 2.03 (0.72,5.73) 0.1806
Chronic Obstructive Pulmonary Disease 11 (1.8%) 16 (0.9%) 2.10 (0.97,4.56) 0.0594
Chronic Viral Hepatitis Disease 80 (13.1%) 194 (10.5%) 1.29 (0.97,1.70) 0.0762
Cirrhosis 5 (0.8%) 20 (1.1%) 0.76 (0.28,2.02) 0.5758
Coronary Artery Disease 22 (3.6%) 49 (2.7%) 1.37 (0.82,2.29) 0.2245
Diabetes Mellitus 68 (11.1%) 133 (7.2%) 1.62 (1.19,2.20) 0.0022
Malignancy other than Basal Cell Carcinoma 100 (16.4%) 173 (9.4%) 1.90 (1.46,2.47) <.0001
Tuberculosis other than latent infection 12 (2.0%) 25 (1.4%) 1.46 (0.73,2.93) 0.2831
Mental Health Illnesses
Anxiety Disorder 71 (11.6%) 144 (7.8%) 1.56 (1.15,2.10) 0.0038
Bipolar Disorder 21 (3.4%) 27 (1.5%) 2.41 (1.35,4.29) 0.0029
Major Depression 196 (32.1%) 398 (21.5%) 1.72 (1.41,2.11) <.0001
Post-Traumatic Stress Disorder 11 (1.8%) 26 (1.4%) 1.29 (0.63,2.62) 0.4877
Prior Suicide Attempt 10 (1.6%) 13 (0.7%) 2.35 (1.03,5.39) 0.0431
Substance Abuse 85 (13.9%) 198 (10.7%) 1.35 (1.03,1.77) 0.0315
Serum Levels at Initiation
ALT(U/L) 33.5 (26) 32 (23) 1.00 (1.00,1.00) 0.1366
AST(U/L) 31 (17) 29 (15) 1.00 (1.00,1.00) 0.0945
Total Bilirubin (mg/dL) 0.6 (0.35) 0.6 (0.4) 1.25 (1.03,1.51) 0.0207
HDL (mg/dL) 37 (15) 39 (15) 0.97 (0.96,0.99) 0.0007
LDL (mg/dL) 97 (38) 101 (41) 1.00 (0.99,1.00) 0.1451
Triglycerides (mg/dL) 133 (122) 110 (92) 1.00 (1.00,1.00) 0.0927
Glucose (mg/dL) 87 (20) 87 (16) 1.00 (1.00,1.01) 0.4271
Creatinine (mg/dL) 1 (0.2) 1 (0.2) 0.79 (0.50,1.24) 0.3023
Hemoglobin(g/dL) 14 (2.1) 14.4 (1.7) 0.85 (0.79,0.91) <.0001

Abbreviations: HAART, highly active antiretroviral therapy; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, high density lipoprotein; LDL, low density lipoprotein